» Articles » PMID: 20114036

Dopamine Receptor Modulation of Repetitive Grooming Actions in the Rat: Potential Relevance for Tourette Syndrome

Overview
Journal Brain Res
Specialty Neurology
Date 2010 Feb 2
PMID 20114036
Citations 36
Authors
Affiliations
Soon will be listed here.
Abstract

Studies of rodent grooming can provide valuable insight for dopamine contributions to the initiation, organization, and repetition of motor patterns. This information is useful for understanding how brain dysfunctions contribute to movement disorders such as Tourette syndrome and obsessive compulsive disorder, in which patients are driven to reiterate particular movement patterns. In rodents, dopamine D1 receptor stimulation causes a complex behavioral super-stereotypy in the form of excessive production and rigid execution of whole sequences of movements known as syntactic grooming chains. Sequential super-stereotypy of grooming chains may be particularly advantageous for modeling movement sequences and treatments in Tourette syndrome and related disorders. Here, we report that co-administration of haloperidol, one available treatment for Tourette syndrome and primarily a D2 receptor antagonist, prevented D1 stimulation with SKF38393 from inducing sequential super-stereotypy, which manifests as an exaggeration of the tendency to complete all four phases of a syntactic chain in rigid serial order once the first phase has begun. In a separate experiment, we showed that in contrast to acute D1 agonist administration, 39h withdrawal from chronic (3weeks) administration of the D1 antagonist SCH23390 (which has been suggested to increase D1 receptor expression in the basal ganglia) did not elicit sequential super-stereotypy after drug cessation. Instead, rats suddenly removed from repeated SCH23390 spent more time performing simple stereotypies that included intense scratching and biting behaviors. Together, these results have implications for understanding how dopamine receptors facilitate particular stereotypies manifest in animal models of Tourette syndrome and obsessive compulsive disorder.

Citing Articles

Neural substrates for regulating self-grooming behavior in rodents.

Li G, Lu C, Yin M, Wang P, Zhang P, Wu J J Zhejiang Univ Sci B. 2024; 25(10):841-856.

PMID: 39420521 PMC: 11494162. DOI: 10.1631/jzus.B2300562.


Temporally aligned segmentation and clustering (TASC) framework for behavior time series analysis.

Zinkovskaia E, Tahary O, Loewenstern Y, Benaroya-Milshtein N, Bar-Gad I Sci Rep. 2024; 14(1):14952.

PMID: 38942770 PMC: 11213853. DOI: 10.1038/s41598-024-63669-6.


Rats Lacking the Dopamine Transporter Display Inflexibility in Innate and Learned Behavior.

Belskaya A, Kurzina N, Savchenko A, Sukhanov I, Gromova A, Gainetdinov R Biomedicines. 2024; 12(6).

PMID: 38927477 PMC: 11200708. DOI: 10.3390/biomedicines12061270.


Hyperactivity of indirect pathway-projecting spiny projection neurons promotes compulsive behavior.

Piantadosi S, Manning E, Chamberlain B, Hyde J, LaPalombara Z, Bannon N Nat Commun. 2024; 15(1):4434.

PMID: 38789416 PMC: 11126597. DOI: 10.1038/s41467-024-48331-z.


Computational insights on asymmetrical and receptor-mediated chunking: implications for OCD and Schizophrenia.

Szalisznyo K, Silverstein D Cogn Neurodyn. 2024; 18(1):217-232.

PMID: 38406202 PMC: 10881457. DOI: 10.1007/s11571-022-09865-4.


References
1.
McDougle C, Goodman W, Price L . Dopamine antagonists in tic-related and psychotic spectrum obsessive compulsive disorder. J Clin Psychiatry. 1994; 55 Suppl:24-31. View

2.
Parashos S, Marin C, Barone P, Chase T . Effect of chronic D-1 and/or D-2 dopamine antagonist treatment on SKF 38393-induced non-stereotyped grooming. Psychopharmacology (Berl). 1990; 102(3):411-3. DOI: 10.1007/BF02244112. View

3.
Albin R, Mink J . Recent advances in Tourette syndrome research. Trends Neurosci. 2006; 29(3):175-82. DOI: 10.1016/j.tins.2006.01.001. View

4.
Frey K, Albin R . Neuroimaging of Tourette syndrome. J Child Neurol. 2006; 21(8):672-7. DOI: 10.1177/08830738060210080501. View

5.
Iorio L, Barnett A, Leitz F, Houser V, Korduba C . SCH 23390, a potential benzazepine antipsychotic with unique interactions on dopaminergic systems. J Pharmacol Exp Ther. 1983; 226(2):462-8. View